Emerging Markets<\/h1>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t

\n\t\t\t\t

\n\t\t\t\t

\n\t\t\t

\n\t\t\t\t\t

\n\t\t\t\t

\n\t\t\t\t

\n\t\t\t\t\t

\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n

Product Name<\/b><\/td>\n	Generic Name<\/b><\/td>\n	Country<\/b><\/td>\n	Composition<\/b><\/td>\n	Therapy<\/b><\/td>\n <\/tr>\n
AZIWOK-500<\/td>\n	Azithromycin Tablets USP 500mg<\/td>\n	Kenya<\/td>\n	Each film coated tablet contains: Azithromycin USP 500 mg Excipients\u2026. Q.S.<\/td>\n	1. macrolide antibiotics Azithromycin is an azalide, a sub-class of the macrolid antibiotics. By binding to the 50S-ribosomal sub-unit, azithromycin avoids the translocation of peptide chains from<\/td>\n <\/tr>\n
one side of the ribosome to the other. As a consequence of this, RNA-dependent protein synthesis in sensitive organisms is prevented<\/td>\n <\/tr>\n
AZIWOK-250<\/td>\n	Azithromycin Tablets USP 250mg<\/td>\n	Kenya<\/td>\n	Azithromycin dihydrate USP Equivalent to Azithromycin 250 mg<\/td>\n	1. macrolide antibiotics<\/td>\n <\/tr>\n
2. Azithromycin is an azalide, a sub-class of the macrolide antibiotics. By binding to the 50S-ribosomal sub-unit, azithromycin avoids the translocation of peptide chains from<\/td>\n <\/tr>\n
one side of the ribosome to the other. As a consequence of this, RNA-dependent protein synthesis in sensitive organisms is prevented<\/td>\n <\/tr>\n
Bro-Zedex cough syrup<\/td>\n	Terbutaline Sulphate Bromhexine HCl Guaifenesin Menthol BP<\/td>\n	Kenya, Myanmar, Uganda<\/td>\n	Each 10 ml contains Terbutaline Sulphate BP 2.5 mg Bromhexine HCL BP 8 mg Guaifenesin BP 100.0 mg Menthol 5 mg<\/td>\n	1. Cough suppressants, expectorants, mucolytic, and natural remedies<\/td>\n <\/tr>\n
2. Bro-zedex dilates the airways so as to produce easier breathing and decreases the initiation of reflex<\/td>\n <\/tr>\n
It increase ciliary activity of the respiratory tract fluid<\/td>\n <\/tr>\n
GLARITUS<\/td>\n	Insulin Glargine 100IU\/ML<\/td>\n	Algeria, Malaysia, Myanmar, Indonesia, Kenya, Nepal, Philippines, Rwanda ,Vietnam , Uganda, Thailand, Tanzania<\/td>\n	Each DispoPen contains : One 3 mL cartridge of Insulin Glargine Injection U.S.P. 100 IU\/mL Each ml contains: Insulin Glargine U.S.P. \u2026..100 IU m-Cresol U.S.P. \u2026\u2026\u2026 0.27% w\/v (as preservative) Water for Injection U.S.P \u2026.. q.s.<\/td>\n	Glaritus 100IU\/ml Injection is a man-made form of insulin that helps to control high blood glucose (sugar) levels. It replaces the insulin that is normally produced in the body. This helps the glucose get into your cells so your body can use it for energy. Lowering of blood sugar level helps reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems, and loss of limbs.<\/td>\n <\/tr>\n
Glutafizz<\/td>\n	Vitamin C 1000mg, L-Glutathione 500mg<\/td>\n	Nepal<\/td>\n	Each serving contains Vitamin C* 1000 mg L-Glutathione (Reduced) 500 mg<\/td>\n	Vitamin C with L-Glutathione for a bright and glowy skin with anti ageing properties<\/td>\n <\/tr>\n
Gut2Go<\/td>\n	Wheat Dextrin, Partially hydrolysed Gaur Gum<\/td>\n	Nepal<\/td>\n	Each serving Contains Wheat Dextrin + 4g Partially Hydrolysed Guar Gum 1g<\/td>\n	Prebiotic Fiber Supplement Gut2Go can be consumed just once a day to boost your Fiber intake. It is the convenient way to add Fiber to any beverage or food #. This Synergy Blend may help to:<\/td>\n <\/tr>\n
1. Grow good bacteria in the gut which boost good digestion ^<\/td>\n <\/tr>\n
2. Lower your cholesterol levels ^ x<\/td>\n <\/tr>\n
3. Maintain blood sugar levels as an element of healthy diet ^ \u221e<\/td>\n <\/tr>\n
4. Feel Fuller ^<\/td>\n <\/tr>\n
Heparin Sodium Injection USP 25000IU\/5ml<\/td>\n	Heparin Sodium Injection USP 25000IU\/5ml<\/td>\n	Kenya<\/td>\n	COMPOSITION Each ml contains: Heparin Sodium USP 1000 IU \/ 5000 IU Benzyl Alcohol USP 1.5% v\/v Water For Injection USP q.s.<\/td>\n	Heparin is a heterogeneous group of straight-chain anionic mucopolysaccharides, called glycosaminoglycan\u2019s, possessing anticoagulant properties. It is composed of polymers of alternating derivations of \u03b1-D-glucosamido (N-sulphated O-sulphated or Nacetylated) and O-sulphated uronic acid (\u03b1-L-iduronic acid or \u03b2-D-glucuronic acid).<\/td>\n <\/tr>\n
Kefstar 750 mg Injection<\/td>\n	Cefuroxime Axetil 750mg USP<\/td>\n	Kenya<\/td>\n	Each vial contains : Sterile Cefuroxime Sodium USP equivalent to Cefuroxime 750 mg B) One disposable sterile syringe and needle and One ampoule containing 10 ml of Sterilised Water for Injections B.P<\/td>\n	KEFSTAR (Cefuroxime Sodium) is a semi-synthetic, broad-spectrum cephalosporin antibiotic for injectable use. Cefuroxime is usually bactericidal in action. Its action results from the inhibition of mucopeptide synthesis in the bacterial cell wall<\/td>\n <\/tr>\n
Kefstar-500 tablets<\/td>\n	Cefuroxime Axetil 500mg USP<\/td>\n	Kenya<\/td>\n	Each film coated tablet contains: Cefuroxime Axetil USP equivalent to anhydrous Cefuroxime\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.500 mg<\/td>\n	Cefuroxime is indicated for the treatment of the following infections: Pharyngitis and tonsillitis caused by S. pyogenes (group A beta-haemolytic strepto cocci). Otitis media (acute bacterial) caused by S. pneumoniae, H. influenza (beta-lactamase producing strains), M. catarrhalis (beta lactamase- producing strains) and S. pyogenes Acute bacterial maxillary sinusitis caused by S. pneumoniae or H. influenzas (non-beta-lactamase-producing strains only) Acute bacterial exacerbations of chronic bronchitis and secondary bacterial infections of acute bronchitis caused by S. pneumoniae, H. influenzas (beta-lactamase-negative strains) or H. parainfluenzae (beta lactamase- negative strains)<\/td>\n <\/tr>\n
MANIX HERBAL CAPSULES<\/td>\n	<\/td>\n	Kenya<\/td>\n	Each MANIX capsule contains: Asparagus racemosus (Shatavari) Extract 42.0 mg Cinnamomum tamala (Tamalpatra) Powder 16.5 mg Cinnamomum zeylanicum (Dalchini) Powder 16.5 mg Dioscorea bulbifera (Varahikand) Powder 207.0 mg Elettaria cardamomum (Elaichi) Powder 16.5 mg Plumbago zeylanica (Chitrak) Extract 85.0 mg Pueraria tuberosa (Vidarikand) Extract 10 mg Semecarpus anacardium (Godambi) Extract 45.0 mg Sesamum indicum (Kalatil) Powder 99.0 mg Tinospora cordifolia (Guduchi) Extract 40.0 mg Tribulus terrestris (Gokshru) Extract 45.0 mg Sodium Benzoate BP 0.2% w\/w<\/td>\n	MANIX capsule is a polyherbal formulation of indigenous medicinal herbs. The combination contain various phytochemicals like essential oils, glycosides, saponins, isoflavones, biflavones, alkaloids, lactones, steroids, phenolics, aliphatic compounds and polysaccharides as the active components. MANIX is a clinically proven combination of the unique herbal ingredients in the treatment of male sexual disorders<\/td>\n <\/tr>\n
Merimix<\/td>\n	Meropenem Trihydrate<\/td>\n	Tanzania<\/td>\n	Meropenem USP (as trihydrate) Equivalent to anhydrous Meropenem\u2026\u2026.1000 mg Sodium (as sodium carbonate IP)\u2026\u2026\u2026\u202690.2 mg Sulbactam Sodium USP Equivalent to Sulbactam\u2026\u2026\u2026\u2026\u2026\u2026\u2026..500 mg<\/td>\n	Meropenem\/Sulbactam for Injection I.V. is useful as presumptive therapy in the indicated condition (e.g., intraabdominal infections) prior to the identification of the causative organisms because of its broad spectrum of bactericidal activity<\/td>\n <\/tr>\n
MYPEN<\/td>\n	INSULIN DELIVERY DEVICE<\/td>\n	Srilanka<\/td>\n	INSULIN DELIVERY DEVICE<\/td>\n	It is an innovative insulin pen designed for precise and convenient insulin delivery. This pen is suitable for individuals with diabetes who require insulin therapy to manage their blood sugar levels.<\/td>\n <\/tr>\n
NADIMIX CREAM<\/td>\n	NADIFLOXACIN, MICONAZOLE NITRATE, MOMETASONE FUROATE<\/td>\n	Kenya, Myanmar<\/td>\n	Each gm contains Nadifloxacin \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 10 mg Miconazole Nitrate BP \u2026\u2026\u2026.. 20 mg Mometasone Furoate USP .. 01 mg<\/td>\n	Nadofloxacin is systemic quinolone with potent broad spectrum antibacterial activity . Miconazole is a potent imidazole antifungal with a broad anti fungal spectrum . Mometasone furoate a moderately potent coticosteroids has been shown to have topical systemic pharmacological and metabolic effects characteristics of this class of drugs<\/td>\n <\/tr>\n
Nadoxin Cream<\/td>\n	Nadifloxacin 10mg\/g<\/td>\n	Kenya, Myanmar, Uganda, Tanzania<\/td>\n	Each gram of cream contains Nadifloxacin 10 mg In a cream base q.s.<\/td>\n	Nadoxin is synthetic quinolone with potent broad spectrum antibacterial activity . It is intended for the treatment of acne vulgaris caused by propionibacterium acnes and staphylococcus spp. Prominent efficacy , low potential in including resistance in microorganism and high acterial activity against drug resistant microorgannism<\/td>\n <\/tr>\n
Nuroday tablet<\/td>\n	Mecobalamin JP 1500mcg\/ extended release tablet<\/td>\n	Myanmar<\/td>\n	Composition Each Extended Release tablet contains: Mecobalamin JP \u2026.. 1500 mcg<\/td>\n	Man-made form of Vitamin B12 which is important for nerve health, brain function, and red blood cell production. This medicine is mainly used to treat Vitamin B12 deficiency in people with anaemia and peripheral neuropathy (nerve pain in hands and feet)<\/td>\n <\/tr>\n
PHYTON 2.25g<\/td>\n	Piperacillin and Tazobactam for injection USP<\/td>\n	Kenya, Zambia<\/td>\n	Each vial contains: Sterile Piperacillin Sodium USP Equivalent to Piperacillin\u2026\u20262.0g Sterile Tazobactam Sodium Equivalent to Tazobactam\u2026\u20260.25g Sodium .4.46mEq (102.5 mg)<\/td>\n	Severe pneumonia including hospital-acquired and ventilator-associated pneumonia Complicated urinary tract infections (including pyelonephritis) \u2013 Complicated intra-abdominal infections \u2013 Complicated skin and soft tissue infections (including diabetic foot infections) -Treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. \u2013 Piperacillin\/Tazobactam may be used in the management of neutropenic patients with fever suspected to be due to a bacterial infection.<\/td>\n <\/tr>\n
PHYTON 4.5g<\/td>\n	Piperacillin and Tazobactam for injection USP<\/td>\n	Kenya, Zambia<\/td>\n	Sterile Piperacillin Sodium USP equivalent to Piperacillin \u2026\u2026\u2026\u2026\u2026.\u20264.0 G Tazobactam Sodium equivalent to Tazobactam\u2026\u2026\u2026\u2026\u2026\u2026.0.5 G Sodium 8.9meq (205mg)<\/td>\n	Severe pneumonia including hospital-acquired and ventilator-associated pneumonia -Complicated urinary tract infections (including pyelonephritis) \u2013 Complicated intra-abdominal infections \u2013 Complicated skin and soft tissue infections (including diabetic foot infections) -Treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. \u2013 Piperacillin\/Tazobactam may be used in the management of neutropenic patients with fever suspected to be due to a bacterial infection<\/td>\n <\/tr>\n
Powercef Injection 1 gm<\/td>\n	Ceftriaxone Sodium 1 gm<\/td>\n	Kenya, Myanmar, Uganda, Tanzania<\/td>\n	Each vial contains: Sterile Ceftriaxone Sodium USP equivalent to anhydrous Ceftriaxone \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.. 1 g<\/td>\n	POWERCEF is a sterile, semisynthetic, broad-spectrum cephalosporin antibiotic for intravenous or intramuscular administration. The bactericidal activity of Ceftriaxone results form the inhibition of cell wall synthesis. Ceftriaxone demonstrates a high degree of stability in the presence of Blactamases both penicillinases and cephalosporins of gram-negative and gram-positive bacteria. Ceftriaxone is usually active against following micro-organisms invitro.<\/td>\n <\/tr>\n
Wepox 2000<\/td>\n	Recombinant Human Erythropoetin Injection 2000 IU<\/td>\n	Srilanka, Tanzania, Uganda<\/td>\n	Each 0.5 ml contains : Recombinant Human Erythropoietin 2000 IU<\/td>\n	Treatment of anaemia due to erythropoietin deficiency in adult chronic renal failure patients and in predialysis, haemodialysis, peritoneal dialysis patients and in paediatric patients on haemodialysis. Treatment of anaemia in cancer patients with non-myeloid malignancies (with or without chemotherapy) and prevention of anemia in cancer patients with non-myeloid malignancies who are undergoing chemotherapy treatment. Treatment of anaemia in HIV-infected patients on zidovudine with endogenous erythropoietin levels \u2264500 mU\/ml.<\/td>\n <\/tr>\n
Wepox 4000<\/td>\n	Recombinant Human Erythropoetin Injection 4000 IU<\/td>\n	Srilanka, Tanzania, Uganda<\/td>\n	Each 0.4 ml contains : Recombinant Human Erythropoietin 4000 IU<\/td>\n	Treatment of anaemia due to erythropoietin deficiency in adult chronic renal failure patients and in predialysis, haemodialysis, peritoneal dialysis patients and in paediatric patients on haemodialysis. Treatment of anemia in cancer patients with non-myeloid malignancies (with or without chemotherapy) and prevention of anemia in cancer patients with non-myeloid malignancies who are undergoing chemotherapy. Treatment of anemia in HIV-infected patients on zidovudine with endogenous erythropoietin levels \u2264500 mU\/ml. To aid autologous blood collection in patients scheduled for elective surgery, with hematocrits of 33- 39%, who cannot produce the required blood without exogenous erythropoietin.<\/td>\n <\/tr>\n
Wepox 5000<\/td>\n	Recombinant Human Erythropoetin Injection 5000 IU<\/td>\n	Srilanka, Tanzania, Uganda<\/td>\n	Each 0.5 ml contains : Recombinant Human Erythropoietin 5000 IU<\/td>\n	WEPOX is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF):<\/td>\n <\/tr>\n \n
In adults and paediatrics aged 1 to 18 years on haemodialysis and adult patients on peritoneal dialysis.<\/td>\n <\/tr>\n
In adults with renal insufficiency not yet undergoing dialysis for the treatment of severe anaemia of renal origin accompanied by clinical symptoms in patients.<\/td>\n <\/tr>\n \n
Wepox 10000<\/td>\n	Recombinant Human Erythropoetin Injection 10000 IU<\/td>\n	Srilanka, Tanzania, Uganda<\/td>\n	Each 1 ml contains : Recombinant Human Erythropoietin 10000 IU<\/td>\n	This medicine is primarily indicated for treating anemia (low red blood cell count) in persons with long-term serious (chronic) kidney disease, persons receiving chemotherapy for some types of cancer except for bone marrow or blood cells cancer, and persons taking zidovudine to treat HIV(human immunodeficiency virus).<\/td>\n <\/tr>\n
Wepox 30000<\/td>\n	Recombinant Human Erythropoetin Injection 30000 IU<\/td>\n	Srilanka, Tanzania, Uganda<\/td>\n	Each Cartridge (3.0 ml) for pen contains: Recombinant Human Erythropoietin Ph. Eur. 30000 IU<\/td>\n	WEPOX is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF):<\/td>\n <\/tr>\n \n
In adults and paediatrics aged 1 to 18 years on haemodialysis and adult patients on peritoneal dialysis.<\/td>\n <\/tr>\n
In adults with renal insufficiency not yet undergoing dialysis for the treatment of severe anaemia of renal origin accompanied by clinical symptoms in patients.<\/td>\n <\/tr>\n\n
WEPOX is indicated in adults receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient\u2019s general status (e.g. cardiovascular status, pre-existing anaemia at the start of chemotherapy) for the treatment of anaemia and reduction of transfusion requirements.<\/td>\n <\/tr>\n
Wosulin N<\/td>\n	Insulin Injection, Isophane 100 IU<\/td>\n	Mozambique, Myanmar, Kenya, Nepal, Philippines, Nigeria, Srilanka, Tanzania, Thailand, Vietnam<\/td>\n	Each mL contains Human Insulin IP\/USP\/Ph.Eur 100 IU m-Cresol USP\/ Ph.Eur (As preservative) 0.16% w\/v Phenol IP\/USP\/Ph.Eur (As preservative) 0.065 w\/v Water for Injections IP\/USP\/Ph.Eur Q.S.<\/td>\n	Isophane insulin human suspension -N is indicated for the following<\/td>\n <\/tr>\n \n
1. Treatment of all patient with type 1 diabetes<\/td>\n <\/tr>\n
2. Treatment of patient with type 2 diabetes who are not adequately controlled by diet and oral hypoglycemic agents<\/td>\n <\/tr>\n
3. Treatment of gestational diabetes<\/td>\n <\/tr>\n
4. For initial stabilization of diabetes in patient with diabetic ketoacidosis , hypersmolar non ketotic syndrome and during periods of stress such as severe infection and major surgery in diabetic patients.<\/td>\n <\/tr>\n \n
Wosulin R<\/td>\n	Insulin Injection, Soluble 100 IU<\/td>\n	Mozambique, Myanmar, Kenya, Nepal, Philippines, Nigeria, Srilanka, Tanzania, Thailand, Vietnam<\/td>\n	Each mL contains Human Insulin IP\/USP\/Ph.Eur 100 IU m-Cresol USP\/ Ph.Eur (As preservative) 0.25% w\/v Water for Injections IP\/USP\/Ph.Eur Q.S.<\/td>\n	Insulin human regular is indicated for the following<\/td>\n <\/tr>\n
1. Treatment of all patient with type 1 diabetes<\/td>\n <\/tr>\n
2. Treatment of patient with type 2 diabetes who are not adequately controlled by diet and oral hypoglycemic agents<\/td>\n <\/tr>\n
3. Treatment of gestational diabetes<\/td>\n <\/tr>\n
4. For initial stabilization of diabetes in patient with diabetic ketoacidosis , hypersmolar non ketotic syndrome and during periods of stress such as severe infection and major surgery in diabetic patients.<\/td>\n <\/tr>\n
Wosulin 30\/70<\/td>\n	Insulin Injection, Biphasic Isophane 100 IU<\/td>\n	Mozambique, Myanmar, Kenya, Nepal, Philippines, Nigeria, Srilanka, Tanzania, Thailand, Vietnam<\/td>\n	Each mL contains: Insulin Human USP 100 IU (30% Regular Insulin Human neutral and 70% Isophane Insulin) m-Cresol USP 0.16% w\/v as preservative Phenol USP 0.065 w\/v as preservative Water for Injection USP q.s.<\/td>\n	WOSULIN-30\/70 is indicated for the following:<\/td>\n <\/tr>\n\n
Treatment of all patients with type 1 diabetes<\/td>\n <\/tr>\n
Treatment of patients with type 2 diabetes who are not adequately controlled by diet and \/ or oral hypoglycemic agents.<\/td>\n <\/tr>\n
For the initial stabilization of diabetes in patients with diabetic ketoacidosis, hyperosmolar non-ketotic syndrome and during periods of stress such as severe infections and major surgery in diabetic patients.<\/td>\n <\/tr>\n
Treatment of Gestational diabetes.<\/td>\n <\/tr>\n\n
Wosulin N<\/td>\n	Insulin Injection, Isophane 40 IU<\/td>\n	Nepal<\/td>\n	Each ml of Insulin isophane contains Human insulin USP 40 IU m-cresol USP \u2013 preservative 0.16% w\/w Phenol USP \u2013 preservative 0.065% w\/w water for injection USP<\/td>\n	Wosulin-N 40IU\/ml Suspension for Injection is an intermediate-acting type of insulin that is usually used along with other diabetes medication for controlling blood sugar levels. It replaces the insulin that is normally produced in the body. This helps the glucose get into your muscle and fat cells so your body can use it for energy. It also decreases glucose production in the liver.<\/td>\n <\/tr>\n
Wosulin R<\/td>\n	Insulin Injection, Soluble 40 IU<\/td>\n	Nepal<\/td>\n	Each ml contains Human insulin USP 40 IU m-cresol USP \u2013 preservative 0.25% w\/w water for injection USP<\/td>\n	Treatment of all patients with type 1 diabetes<\/td>\n <\/tr>\n\n
Treatment of patients with type 2 diabetes who are not adequately controlled by diet and \/ or oral hypoglycemic agents.<\/td>\n <\/tr>\n
For the initial stabilization of diabetes in patients with diabetic ketoacidosis, hyperosmolar non-ketotic syndrome and during periods of stress such as severe infections and major surgery in diabetic patients.\u00a0<\/td>\n <\/tr>\n
Treatment of Gestational diabetes<\/td>\n <\/tr>\n \n
Wosulin 30\/70<\/td>\n	Insulin Injection, Biphasic Isophane 40 IU<\/td>\n	Nepal<\/td>\n	Each mL contains: Insulin Human USP 40IU (30% Regular Insulin Human neutral and 70% Isophane Insulin) m-Cresol USP 0.16% w\/v as preservative Phenol USP 0.065 w\/v as preservative Water for Injection USP q.s.<\/td>\n	Treatment of all patients with type 1 diabetes<\/td>\n <\/tr>\n \n
Treatment of patients with type 2 diabetes who are not adequately controlled by diet and \/ or oral hypoglycemic agents.<\/td>\n <\/tr>\n
For the initial stabilization of diabetes in patients with diabetic ketoacidosis, hyperosmolar non-ketotic syndrome and during periods of stress such as severe infections and major surgery in diabetic patients.<\/td>\n <\/tr>\n \n
Treatment of Gestational diabetes<\/td>\n <\/tr>\n
Wokadine solution<\/td>\n	Povidone Iodine solution 10 % w\/v<\/td>\n	Kenya<\/td>\n	Povidone-Iodine USP 10% w\/v (Available Iodine 1% w\/v)<\/td>\n	General Surgery: For peritoneal lavage in peritonitis to decontaminate peritoneal cavity. For irrigation of operative wounds before closure, especially after abdominal operations.<\/td>\n <\/tr>\n \n
Plastic Surgery: For decontamination of traumatic wounds. For preoperative preparation of area before skin grafting.<\/td>\n <\/tr>\n
Urosurgery: Preoperative urinary bladder instillation in the course of transurethral operations. During routine catheterisation to prevent postcatheterisation infection rate.<\/td>\n <\/tr>\n
Colo-rectal Surgery: For preoperative colonic wash for decontamination of colon. Intraoperative wash of the affected segment for regional antisepsis.<\/td>\n <\/tr>\n
Orthopaedic Surgery: For painting the affected limb prior to immobilizing it in a plaster of paris cast. For washing osteomyletic cavity<\/td>\n <\/tr>\n\n
Wokadine Spray<\/td>\n	Povidone Iodine Spray 0.45% w\/v<\/td>\n	Kenya<\/td>\n	Povidone-Iodine USP 0.45% w\/v (Available iodine 0.045 % w\/v)<\/td>\n	Povidone-Iodine Sore Throat Spray is indicated for the symptomatic relief of painful, irritated sore throats. It is effective against bacteria, fungi, yeasts and protozoa. It is used as an antiseptic treatment in the throat. It is non-irritating and non-stinging to skin and mucosa.<\/td>\n <\/tr>\n
Wokadine Ointment<\/td>\n	Povidone Iodine 10% w\/v ointment<\/td>\n	Kenya<\/td>\n	Povidone-Iodine USP 10% w\/w (Available Iodine 1% w\/w)<\/td>\n	For the topical treatment or prevention of infection in minor cuts and abrasions, minor surgical procedures and small areas of burns.<\/td>\n <\/tr>\n\n
Treatment of mycotic and bacterial skin infections and pyoderma.<\/td>\n <\/tr>\n
Treatment of infections in decubitus and stasis ulcers.<\/td>\n <\/tr>\n
Degerming skin in hyperalimentation and catheter care.<\/td>\n <\/tr>\n
Wokadine Gargle<\/td>\n	Povidone Iodine Gargle 1% w\/v<\/td>\n	Kenya<\/td>\n	Povidone Iodine USP 1 % w\/v (Available Iodine 0.1 % w\/v) Absolute Alcohol 8.38 % v\/v in a specially denatured vehicle In a mint flavoured base q.s.<\/td>\n	For inflammatory conditions of the mouth and pharynx caused by bacterial or monilial infections including pharyngitis, tonsillitis, aphthous ulcers, stomatitis, gingivitis,glossitis, secondary infected traumatic or herpetic ulcers<\/td>\n <\/tr>\n\n
In dental surgery and oral operative procedures.<\/td>\n <\/tr>\n
In pericoronitis.<\/td>\n <\/tr>\n
IAs a prophylactic mouthwash.<\/td>\n <\/tr>\n
To deodorize and refresh the mouth in febrile, post-operative or bed-ridden<\/td>\n <\/tr>\n
patients and others who require the promotion of oral hygiene<\/td>\n <\/tr>\n
Wokadine Scrub<\/td>\n	Povidone Iodine Scrub<\/td>\n	Kenya<\/td>\n	Povidone-Iodine USP 7.5% w\/v (Available Iodine 0.75% w\/v) Non-ionic Detergent base q.s.<\/td>\n	Broad spectrum topical microbicidal effective against bacteria, fungi, protozoa, yeasts and viruses<\/td>\n <\/tr>\n
ZEDEX D capsule<\/td>\n	ACETAMINOPHEN 325MG, DEXTROMETHORPHAN HYDROBROMIDE 10MG,DOXYLAMINE SUCCINATE 6.25MG<\/td>\n	Uganda<\/td>\n	Composition Each Soft Gelatin Capsule Contains: Acetaminophen USP 325 mg Dextromethorphan Hydrobromide USP 10 mg Doxylamine Succinate USP 6.25 mg Excipients q.s.<\/td>\n	For temporary relief in common cold and flu symptoms like minor aches and pains, headache, sore throat, fever, sneezing, runny nose and cough due to minor throat and bronchial irritation.<\/td>\n <\/tr>\n
ZEDEX<\/td>\n	Bromhexine Hydrochloride BP Dextromethorphan Hydrobromide BP<\/td>\n	KENYA<\/td>\n	Each 10 ml contains Bromhexine Hydrochloride BP 8 mg Dextromethorphan Hydrobromide BP 10 mg Ammonium Chloride BP 100 mg Menthol BP 5 mg Flavoured sryupy base q.s Colours : Briliant blue FCF and Tartrazine<\/td>\n	For the symptomatic treatment of irritating and hacking cough, cough associated with URTI, bronchitis, pulmonary congestion where retention of tenacious and viscid mucoid secretion is a problem.<\/td>\n <\/tr>\n
ZEDEX COLD capsule<\/td>\n	ACETAMINOPHEN 325MG, DEXTROMETHORPHAN HYDROBROMIDE 10MG,DOXYLAMINE SUCCINATE 6.25MG<\/td>\n	Nigeria , uganda<\/td>\n	Each Soft Gelatin Capsule Contains: Acetaminophen USP 325 mg Dextromethorphan Hydrobromide USP 10 mg Phenylephrine Hydrochloride USP 5 mg Excipients q.s.<\/td>\n	For temporary relief in common cold and flu symptoms like minor aches and pains, headache, sore throat, fever, nasal congestion and cough due to minor throat and bronchial irritation.<\/td>\n <\/tr>\n<\/table>\n<\/div><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":" Emerging Markets Product Name Generic Name Country Composition Therapy AZIWOK-500 Azithromycin Tablets USP 500mg Kenya Each film coated tablet contains: Azithromycin USP 500 mg Excipients\u2026. Q.S. 1. macrolide antibiotics Azithromycin is an azalide, a sub-class of the macrolid antibiotics. By binding to the 50S-ribosomal sub-unit, azithromycin avoids the translocation of peptide chains from one side … <\/p>\n Continue reading “Emerging Markets”<\/span><\/a><\/p>\n","protected":false},"author":4,"featured_media":0,"parent":10430,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"yoast_head":"\n